Byshevsky A S, Mukhacheva I A
Vopr Med Khim. 1975 Jul-Aug;21(4):367-70.
A lipid anticoagulant (ether extract of brain tissue) after repeated treatment with alcohol and acetone contained, mainly, ethanolamine phosphatides and sphingomyelin. The product inhibited the conversion of prothrombin into thrombin due to interaction of the lipid anticoagulant with the substrate (prothrombin). The anticoagulant inhibited also the reaction of thrombin with fibrinogen, producing a kind of "coupling inhibition" as shown by graphical analysis of the inhibition kinetics. A fraction of the anticoagulant, enriched in ethanolamine phosphatides and a fraction, enriched in sphingomyelin, possessed the both types of the activity. But the fraction enriched in the ethanolamine phosphatides inhibited more distinctly the reaction between thrombin and fibrinogen. Kinetics of inhibition of thrombinogenesis and thrombin -- fibrinogen reaction by both anticoagulant fractions and initial anticoagulant was similar.
一种脂质抗凝剂(脑组织的乙醚提取物)在经过酒精和丙酮反复处理后,主要含有乙醇胺磷脂和鞘磷脂。由于脂质抗凝剂与底物(凝血酶原)相互作用,该产物抑制凝血酶原向凝血酶的转化。抗凝剂还抑制凝血酶与纤维蛋白原的反应,通过对抑制动力学的图形分析表明产生了一种“耦合抑制”。富含乙醇胺磷脂的抗凝剂部分和富含鞘磷脂的部分都具有这两种活性。但富含乙醇胺磷脂的部分对凝血酶与纤维蛋白原之间反应的抑制更为明显。两种抗凝剂部分以及初始抗凝剂对凝血酶生成和凝血酶 - 纤维蛋白原反应的抑制动力学相似。